Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Elutia Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 18 | 19 | +1 |
| Shares | 2.78M | 3.06M | +281.3K (+10.1%) |
| Value | $4.20M | $7.23M | +$3.03M (+72.1%) |
New holders (4)
Institutions that held Elutia Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Verdence Capital Advisors LLC | 14,410 | $34.0K | 0.00% |
| Millennium Management LLC | 13,302 | $31.4K | 0.00% |
| BerganKDV Wealth Management, LLC | 4,000 | $9.44K | 0.00% |
| Royal Bank of Canada | 108 | $0 | 0.00% |
Sold out (3)
Institutions that held Elutia Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Brown Advisory Inc | 32,887 | $49.7K |
| Jane Street Group, LLC | 19,042 | $28.8K |
| Tower Research Capital LLC (TRC) | 5,134 | $8.00K |